Itoh H, Fujii Y, Kamisada M, Kamishima K, Koga Y, Masuda Y, Miura S, Nabeta Y, Nakano Y, Ogita K
Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(1):39-49. doi: 10.1016/0278-5846(84)90134-9.
An epidemiological study was undertaken, taking a survey of 2,274 chronic schizophrenic patients hospitalized for 2 years or more in 17 mental institutions in Japan. The overall prevalence of tardive dyskinesia (T.D.) was 19.1%. The prevalence of TD differs considerably from one institution to the other, with a range of 0 to 36.1%. The longer the history of institution was, the higher the prevalence of TD. The prevalence showed a tendency to increase with increasing age. Long-term hospitalization concomitant with continuous neuroleptic medication seemed to play a role in the prevalence of TD. TD occurred with higher frequency in patients with somatic complications than in those without complications. Past drug history, including duration of treatment and responsible neuroleptics, has been considered to play an important role in the prevalence of TD. But, results of the present investigation showed that the present drug status might also influence on the appearance of TD. The facts obtained from the present study are of value to establish regimens mainly based on medical treatment for prediction and prevention of TD.
开展了一项流行病学研究,对日本17家精神病院住院2年及以上的2274例慢性精神分裂症患者进行了调查。迟发性运动障碍(TD)的总体患病率为19.1%。TD的患病率在不同机构之间差异很大,范围为0至36.1%。住院时间越长,TD的患病率越高。患病率呈现出随年龄增长而增加的趋势。长期住院并持续使用抗精神病药物似乎在TD的患病率中起作用。有躯体并发症的患者中TD的发生频率高于无并发症的患者。过去的用药史,包括治疗持续时间和相关抗精神病药物,被认为在TD的患病率中起重要作用。但是,本调查结果表明,当前的用药状况也可能影响TD的出现。从本研究中获得的事实对于建立主要基于药物治疗的方案以预测和预防TD具有价值。